Arteris, Inc. (NASDAQ:AIP) Short Interest Update

Arteris, Inc. (NASDAQ:AIP) saw a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 356,200 shares, a growth of 15.6% from the December 31st total of 308,100 shares. Based on an average daily volume of 204,000 shares, the days-to-cover ratio is currently 1.7 days. Currently, 1.4% of the shares of the company are short sold.

Wall Street Analyst Weigh In

Separately, Rosenblatt Securities reissued a “buy” rating and issued a $15.00 target price on shares of Arteris in a report on Wednesday, November 6th.

Arteris Price Performance

NASDAQ AIP opened at $11.21 on Friday. The company has a market cap of $450.42 million, a PE ratio of -11.68 and a beta of 1.17. Arteris has a 52-week low of $5.76 and a 52-week high of $12.64. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16. The firm’s 50 day moving average price is $10.28 and its 200-day moving average price is $8.56.

Insider Buying and Selling

In related news, CFO Nicholas B. Hawkins sold 19,299 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $8.14, for a total transaction of $157,093.86. Following the completion of the transaction, the chief financial officer now directly owns 192,414 shares in the company, valued at approximately $1,566,249.96. The trade was a 9.12 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Isabelle F. Geday sold 15,550 shares of the firm’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $9.03, for a total transaction of $140,416.50. Following the sale, the director now owns 121,213 shares in the company, valued at $1,094,553.39. The trade was a 11.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 325,456 shares of company stock worth $3,355,352. 33.70% of the stock is owned by insiders.

Institutional Trading of Arteris

Several hedge funds and other institutional investors have recently bought and sold shares of AIP. Needham Investment Management LLC lifted its stake in shares of Arteris by 14.7% during the 3rd quarter. Needham Investment Management LLC now owns 2,735,000 shares of the company’s stock worth $21,114,000 after purchasing an additional 350,000 shares during the last quarter. Franklin Resources Inc. lifted its position in shares of Arteris by 0.8% during the third quarter. Franklin Resources Inc. now owns 1,491,415 shares of the company’s stock valued at $11,201,000 after buying an additional 12,375 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Arteris by 6.6% in the 3rd quarter. Geode Capital Management LLC now owns 597,116 shares of the company’s stock valued at $4,610,000 after buying an additional 36,908 shares in the last quarter. State Street Corp grew its position in shares of Arteris by 18.5% in the 3rd quarter. State Street Corp now owns 410,578 shares of the company’s stock worth $3,170,000 after buying an additional 64,081 shares during the last quarter. Finally, Essex Investment Management Co. LLC bought a new position in shares of Arteris during the 3rd quarter worth approximately $2,504,000. Institutional investors own 64.36% of the company’s stock.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.